Newswise — Milan, Italy—November 9, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual European Congress Issue Panel 2 explored the issue of, “Possible Increased Synergy Between Health Technology Assessment (HTA) and Regulatory Agencies: Opportunity or Challenge for Medical Devices?.” This issue panel was held this morning at the MiCo – Milano Congressi in Milan, Italy.
The issue panel was moderated by Christopher Henshall, PhD, Associate Professor, Health Economics Research, Brunel University, London, UK and included panelists:- Pascale Brasseur, EconD, Chair, HTA Working Group, Eucomed, Brussels, Belgium- Les Levin, MA, MD, Founding Chief Scientific Officer, MaRS EXCITE, Toronto, ON, Canada- François Meyer, MD, Advisor to the President, International Affairs, French National Authority for Health (HAS), Paris, France
Released presentations from the ISPOR 18th Annual European Congress are available at www.ispor.org/Event/ReleasedPresentations/2015Milan. ISPOR’s 18th Annual European Congress may be followed on social media using the hashtag #ISPORMilan.
ISPOR’s Medical Devices and Diagnostics Special Interest Group is currently developing a report on the challenges and possible solutions for value assessment of medical devices through their Value Assessment of Medical Device Working Group.
ABOUT ISPORThe International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ISPOR.org | LinkedIn: www.bit.ly/ISPOR-IN | Twitter: www.bit.ly/ISPOR-T (@ISPORorg) | YouTube: www.bit.ly/ISPOR-YT |Facebook: www.bit.ly/ISPOR-FB
RSS